• Objective: To analyze the costs and benefits of alternate cervical cancer screening schedules among elderly women. • Setting: Population-based screening programs. • Design: A Markov model predicts the outcomes of periodic screening, diagnosis, and treatment for cervi-cal cancer among women from 65 to 109 years of age. • Patients: A hypothetical cohort of one million 65-year-old women, representative of the U.S. population
Objective: Evaluate the characteristics and screening history of patients diagnosed with cervical ca...
118 p.Thesis (Ph.D.)--University of Illinois at Urbana-Champaign, 2007.Recent studies have failed to...
ObjectiveGiven that cervical cancer incidence rates do not decline in women >65, there is general...
Background: 2017 US Preventive Services Task Force guidelines for screening cervical cancer and pre-...
Objective: To estimate costs and outcomes of conven-tional annual Papanicolaou (Pap) test screening ...
ImportanceMany cervical cancer screening strategies are now recommended in the United States, but th...
World Health Organization guidelines recommend that cervical cancer screening programs should priori...
Objective: To estimate the cost-effectiveness of altering the currently recommended interval and age...
Background: Studies suggest that cervical cancer screening practice in the United States is ineffici...
Thesis (Ph.D.)--University of Washington, 2013<bold>Aim.</bold> Though cervical cytology screening h...
Objective: To provide easy to use estimates of the benefits and harms of biennial screening mammogra...
To analyze the cervical screening history in women with cervical cancer and their outcome
Cervical cancer is the second most common cancer in women around the world, and the human papillomav...
Importance: Evidence on the relative benefits and harms of primary high-risk human papillomavirus (h...
Cervical cancer screening in the United States has accompanied profound decreases in cancer incidenc...
Objective: Evaluate the characteristics and screening history of patients diagnosed with cervical ca...
118 p.Thesis (Ph.D.)--University of Illinois at Urbana-Champaign, 2007.Recent studies have failed to...
ObjectiveGiven that cervical cancer incidence rates do not decline in women >65, there is general...
Background: 2017 US Preventive Services Task Force guidelines for screening cervical cancer and pre-...
Objective: To estimate costs and outcomes of conven-tional annual Papanicolaou (Pap) test screening ...
ImportanceMany cervical cancer screening strategies are now recommended in the United States, but th...
World Health Organization guidelines recommend that cervical cancer screening programs should priori...
Objective: To estimate the cost-effectiveness of altering the currently recommended interval and age...
Background: Studies suggest that cervical cancer screening practice in the United States is ineffici...
Thesis (Ph.D.)--University of Washington, 2013<bold>Aim.</bold> Though cervical cytology screening h...
Objective: To provide easy to use estimates of the benefits and harms of biennial screening mammogra...
To analyze the cervical screening history in women with cervical cancer and their outcome
Cervical cancer is the second most common cancer in women around the world, and the human papillomav...
Importance: Evidence on the relative benefits and harms of primary high-risk human papillomavirus (h...
Cervical cancer screening in the United States has accompanied profound decreases in cancer incidenc...
Objective: Evaluate the characteristics and screening history of patients diagnosed with cervical ca...
118 p.Thesis (Ph.D.)--University of Illinois at Urbana-Champaign, 2007.Recent studies have failed to...
ObjectiveGiven that cervical cancer incidence rates do not decline in women >65, there is general...